Digital Learning
White Papers
Detect and Characterize In Vitro PCCs of Non-Cleavable ADCs Using a New LC-HRMS Method
Unknowns are Unacceptable
Pharmacokinetic Bioanalysis Strategies for Antibody-Drug Conjugates (ADCs)
Based on LC-MS
The BAMA MINIPIG in Toxicology
ICH M10 Guidance: Harmonization and Modification to Bioanalytical Method Variation
Comparison Between Magnetic Bead and Membrane Immunoaffinity Purification Methods for the Measurement of Monoclonal Antibody in Rat Serum
Internal Standard (IS) Variation Case Studies: Emerging From Three Common IS Challenges
Metabolite Identification (MetID): A Critical Step in Drug Discovery and Development
Bridging Preclinical and Clinical Assays for Biologics Development –Challenges and Considerations for Phase I Trials
The 2019 FDA Guidance’s Implications for Immunogenicity Assessment
Service Catalog
Drug Metabolism and Pharmacokinetics
Brochures
Oligonucleotide Drugs
Antibody Drug Conjugate
Safety Assessment Services
Proteolysis Targeting Chimera
Peptide
Peptide-Drug Conjugate
Webinars
The Strategies and Methods of in-vitro ADME Characterizations of ADCs
DMPK Optimization of Proteolysis-Targeting Chimeras
DMPK Strategies for Oligonucleotide Therapeutics
Hot Topics and Challenges in Drug Development
Expediting Biologics Drug Development: Strategies to Accelerate Preclinical Development Timelines
DMPK Strategies for Successful Clinical Translation
DMPK Addressing Safety Testing of Drug Metabolites (MIST) in Drug Development
AAPS – The Unique Bioanalytical Needs of New Modalities
ICP-MS
Bioanalysis in Gene and Cell Therapy